๐Ÿงช Lab Test (Oxygen-carrying protein / Hgb) ๐Ÿงซ Whole blood (venous) โ€” EDTA anticoagulated (lavender top); often part of CBC/H&H

Hemoglobin: Nursing Guide

Hemoglobin reports how much oxygen-carrying protein is in the blood โ€” a core number nurses pair with fatigue, perfusion, and transfusion decisions. Low Hgb supports anemia workups; high Hgb may reflect dehydration or excess red cells โ€” never read hemoglobin alone or confuse it with glycated hemoglobin (HbA1c).

14 min read
Updated June 20, 2026
Medically Reviewed

Quick Facts

Category
Oxygen-carrying protein
Specimen
EDTA whole blood per hematology protocol
Main nursing risk
Missing symptomatic critical anemia or treating Hgb as
Turnaround
Often same-day

Key Takeaway

Hemoglobin measures oxygen-carrying capacity in blood and is often reported with hematocrit as H&H.

Specimen & Collection Details

Nurse quick-reference for collection prep that affects result quality.

Tube / container

Lavender or purple EDTA hematology tube

EDTA anticoagulant โ€” lavender-top whole blood tube per institutional phlebotomy manual; same tube type as complete blood count when drawn together

Specimen type

Whole blood (venous) โ€” EDTA anticoagulated (lavender top); often part of CBC/H&H

Volume required

Typically one lavender-top venous sample โ€” volume per institutional phlebotomy protocol

Collection timing

Often drawn with CBC on the same lavender tube; coordinate repeat H&H timing with transfusion, bleeding, or therapy monitoring per prescriber orders

Fasting required

No special preparation is usually needed for a hemoglobin or blood count test โ€” follow local laboratory instructions and any guidance for paired tests on the same draw

Transport / storage

Deliver EDTA whole blood to the laboratory per institutional temperature and time limits; hemolysis, clotting, or delayed processing may affect results โ€” follow laboratory protocol

Turnaround time

Often hours to same-day in hospital laboratories โ€” not one universal interval in reviewed references

Lab section

Hematology / complete blood count (CBC) laboratory

What is Hemoglobin?

Hemoglobin is a blood test that measures hemoglobin, the protein in red blood cells that carries oxygen throughout the body. Hemoglobin results help evaluate anemia, polycythemia, bleeding, and response to treatment โ€” and are commonly reported with hematocrit as part of a complete blood count.

Overview

Nurses see hemoglobin on medical units when patients report dizziness and shortness of breath, in preoperative clinics, and when trending H&H after GI bleeding or transfusion. A standalone hemoglobin order or a complete blood count (CBC) both report this value โ€” nurses integrate the number with perfusion, symptoms, and institutional critical-result policy.

Low hemoglobin supports iron deficiency anemia and other anemias when clinical findings agree, yet a single value cannot name the cause. NHLBI anemia guidance describes sickle cell disease, thalassemia, kidney disease, and bleeding among conditions that alter hemoglobin โ€” so nurses trend Hgb with sickle cell anemia, thalassemia history, and prescriber-directed workup rather than labeling disease from one draw alone.

Clinical Nursing Focus

Before interpreting hemoglobin, document bleeding or melena history, review medicines including oral iron, compare today’s Hgb with prior trends, and assess fatigue, dizziness, and vital signs. Reference ranges vary by laboratory, age, and sex โ€” use the reporting interval. Escalate symptomatic anemia, chest pain, or hemodynamic changes per facility policy even when a prior Hgb was acceptable.

Critical Anemia, Bleeding, and Transfusion Safety

Hemoglobin is the bedside anchor for anemia and transfusion decisions, yet one value cannot name cause or rule out active bleeding. The highest-risk nursing errors are reassuring teams because Hgb was acceptable yesterday while melena and tachycardia continue today, and confusing hemoglobin with HbA1c or delaying escalation while crossmatch is pending.

Highest-risk scenarios
  • Symptomatic anemia with tachycardia or hypotension โ€” escalate per protocol regardless of prior acceptable Hgb
  • Rapid Hgb fall with melena or hematemesis while transfusion workup is delayed
  • Critical Hgb with dizziness treated as oral iron only without prescriber review
  • Stable reported Hgb while dyspnea, syncope, or bleeding signs worsen

Document: bleeding history, prior Hgb trend, symptoms, vital signs, transfusion orders, hemoglobin result, prescriber notification, therapy response, and evaluate outcomes after intervention.

What Hemoglobin Can and Cannot Tell You

This test can help identify:

  • Anemia when Hgb is below the reporting reference interval and symptoms align per NHLBI guidance
  • Rising or falling H&H trends during bleeding, transfusion, iron therapy, or marrow suppression
  • Need for additional workup (iron studies, reticulocyte count, peripheral smear) when Hgb is discordant with examination
  • Polycythemia or dehydration context when Hgb is above reference with compatible clinical findings

This test cannot:

  • Diagnose iron deficiency anemia, sickle cell disease, or bleeding source alone
  • Replace HbA1c for diabetes monitoring โ€” glycated hemoglobin is a separate test
  • Rule out symptomatic anemia because a prior Hgb was within reference
  • Determine transfusion need without prescriber orders, symptoms, and institutional policy

Pre-draw Checks for Standalone Hemoglobin

Verify

โœ“Correct patient and hemoglobin or CBC order with serial draw plan noted
โœ“Lavender EDTA tube type per phlebotomy manual
โœ“Baseline fatigue, dizziness, melena or bleeding history, and vital signs
โœ“Parallel orders (repeat H&H, type and screen, iron studies) coordinated
โœ“Oral iron and anticoagulant use documented for interpretation
โœ“Transport plan to laboratory within institutional time limits

Clarify before proceeding when:

  • Symptomatic anemia with tachycardia and low Hgb on concurrent result
  • Recent transfusion or large-volume IV fluids may alter trend interpretation
  • Result conflicts strongly with examination (acceptable Hgb, clear melena)
  • Duplicate Hgb within hours without prescriber indication for serial testing
  • Wrong tube drawn or specimen hemolyzed โ€” validity before treatment decisions
  • Critical Hgb with pending crossmatch and worsening perfusion

Reading Hemoglobin With Symptoms, H&H, and Trends

Integrate hemoglobin with hematocrit, symptoms, bleeding history, reticulocyte response, and iron studies when ordered. Always apply the reporting laboratory reference interval.

Clinical patternHemoglobin contextNursing focus
Melena + falling HgbHgb below reference with tachycardiaNotify prescriber; support transfusion and GI workup per orders
Iron deficiency patternLow Hgb with microcytic indices when smear availableCoordinate iron studies; evaluate outcomes after ferrous sulfate or IV iron
Post-transfusion monitoringRising Hgb with improving perfusionDocument response; continue bleeding surveillance and repeat H&H per orders
Dehydration vs polycythemiaElevated Hgb with hemoconcentration or hypoxia historyCommunicate to prescriber; avoid labeling polycythemia vera without specialist context
โ†” On a small screen, swipe or scroll sideways to see the full table.

Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.

Hemoglobin Trends and False Reassurance at the Bedside

Bedside pointNursing note
H&H togetherTrend hemoglobin with hematocrit โ€” one value rarely drives transfusion alone
Not HbA1cConfirm order type when patients mention diabetes test โ€” different clinical question
Bleeding sourceMelena, menses, or GI loss history belongs in every low-Hgb chart entry
Trend beats snapshotFall from 9.2 to 6.8 g/dL with symptoms needs escalation even if one value seems stable on repeat
Symptom cueDizziness with tachycardia needs escalation even if prior Hgb was acceptable
Evaluate outcomesReassess after transfusion or iron โ€” rising Hgb with ongoing dyspnea needs prescriber review
โ†” On a small screen, swipe or scroll sideways to see the full table.

Why Hemoglobin is Ordered

Hemoglobin is ordered when clinicians need to assess oxygen-carrying capacity, screen for anemia or polycythemia, or monitor response to bleeding, transfusion, or therapy โ€” integrated with history, examination, and confirmatory testing.

Clinical Indication What the Test Answers Nursing Rationale
Suspected anemia with compatible symptoms Do low Hgb and fatigue, pallor, or tachycardia fit anemia per NHLBI guidance? NHLBI anemia guidance describes hemoglobin as central to anemia evaluation when paired with clinical findings โ€” not as a stand-alone diagnosis.
GI or other bleeding with falling H&H Does declining hemoglobin align with melena, hematochezia, or hemodynamic change? NHLBI notes anemia may result from blood loss; nurses trend serial Hgb with perfusion and transfusion plans per orders.
Preoperative or antenatal screening Is baseline Hgb needed before surgery, transfusion planning, or pregnancy monitoring? Routine health screening and preoperative assessment often include hemoglobin among blood count components per institutional protocol.
Monitoring therapy or transfusion response Does Hgb trend with recovery after iron, EPO, or transfusion per prescriber plan? Serial hemoglobin may monitor treatment for anemia โ€” nurses evaluate outcomes with symptoms and reticulocyte count when ordered, not Hgb alone.
โ†” On a small screen, swipe or scroll sideways to see the full table.

Contraindications and Precautions

There is no absolute contraindication to venous blood draw for hemoglobin. Nursing focus is on correct EDTA tube collection, timely communication of critical trends, and preventing misinterpretation at the bedside.

When hemoglobin results must not delay urgent care
  • Symptomatic anemia with tachycardia, hypotension, chest pain, or syncope โ€” escalate per facility policy; do not defer transfusion or bleeding workup while awaiting repeat Hgb alone.
  • Rapid Hgb fall with active bleeding (melena, hematemesis, postpartum hemorrhage) โ€” notify prescriber and activate escalation per orders.
  • Using a prior acceptable Hgb to dismiss today’s symptomatic anemia โ€” trends and examination override isolated prior values.
Interpretation pitfalls
  • Hemoglobin is not HbA1c โ€” glycated hemoglobin reflects long-term glucose control, not oxygen-carrying capacity per NHLBI anemia guidance.
  • Oral iron such as ferrous sulfate may be on the MAR while Hgb is still critically low โ€” document response and avoid assuming supplementation alone resolves urgent anemia.
  • Recent transfusion or IV fluids may shift Hgb โ€” clarify timing before major treatment decisions.
Escalate If
  • Hemodynamic instability, severe shortness of breath, or chest pain with low hemoglobin โ€” activate escalation according to institutional protocol.
  • Hgb falling despite oral iron or with ongoing melena โ€” notify prescriber; evaluate transfusion and source-control plans.
  • Markedly elevated Hgb with headache, erythrocytosis concern, or thrombosis symptoms โ€” communicate to prescriber per orders.

Patient Preparation

Preparation focuses on verifying the order (standalone Hgb vs CBC), documenting baseline symptoms and bleeding history, and coordinating lavender-top collection with paired hematology tests.

Pre-test checks
โœ“Confirm hemoglobin, CBC, or H&H order and whether serial draws are planned.
โœ“Review melena, hematochezia, menses, trauma, and anticoagulant use.
โœ“Document fatigue, dizziness, pallor, shortness of breath, and vital signs.
โœ“Prepare lavender EDTA tube per phlebotomy manual and label before draw.
โœ“Coordinate timing with reticulocyte count, iron studies, or type and screen when ordered.
โœ“Explain hemoglobin reflects oxygen-carrying capacity interpreted with other tests โ€” not a diagnosis alone.
Medications to Review or Hold

Review oral iron, anticoagulants, chemotherapy, and medicines affecting marrow or bleeding โ€” document for interpretation; do not hold prescribed medicines unless the clinician instructs.

Performance โ€” nursing procedure guide

This page is a Tests & Diagnostics guide for Hemoglobin. It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity โ€” not step-by-step performance technique (those live under Nursing Procedures when available).

How the test is performed

Step-by-step technique, supplies, infection prevention, and immediate post-procedure monitoring for this test are covered in:

Venipuncture

Use the Patient preparation, Results and interpretation, and Nursing responsibilities sections on this page for order verification, pre-analytic checks, result follow-up, critical-value escalation, and documentation.

Result follow-up at a glance

Nursing workflow on this page โ€” from order to safe action on results:

1
Confirm indication & correct order
2
Coordinate performance per nursing procedure guide (see above)
3
Document pre-analytic preparation & timing
4
Review result with trend & clinical picture
5
Escalate critical or discordant findings
6
Document communication & patient teaching

Results and Interpretation

Hemoglobin is commonly reported in g/dL (or g/L depending on the laboratory). Interpret using the reporting reference interval, age and sex context, symptoms, hematocrit, red cell indices, and reticulocyte trends when available. Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.

Reference Range Disclaimer

Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.

Result Range / Finding Clinical Meaning Nursing Action
Within reference interval Within laboratory-specific interval for age and sex โ€” use the reporting laboratory reference range; universal numeric thresholds vary by institution โ€” follow the reporting laboratory interval and local policy Hemoglobin within reference may suggest adequate oxygen-carrying capacity when clinical findings agree โ€” not a stand-alone rule-out in ongoing bleeding or marrow suppression Continue clinical monitoring; avoid false reassurance if anemia symptoms or bleeding persist
Borderline / near reference limit Near lower or upper reference limit on reporting laboratory interval Borderline low may warrant repeat H&H and symptom review; borderline high may need correlation with volume status, smoking, or polycythemia workup per clinical context Notify prescriber when symptoms fit; document trend and parallel testing per orders
High / above reference interval Above laboratory reference interval May reflect dehydration, polycythemia vera, chronic hypoxia, or other causes described in NHLBI anemia guidance โ€” requires clinical correlation and often additional hematology evaluation Communicate to prescriber; avoid labeling polycythemia without specialist context; monitor symptoms and evaluate outcomes after treatment
Low / below reference interval Below laboratory reference interval Supports anemia when paired with compatible symptoms per NHLBI guidance โ€” cause requires further workup (iron studies, bleeding evaluation, marrow assessment) Notify prescriber; assess bleeding sources and transfusion or iron therapy needs; monitor symptomatic anemia and evaluate outcomes after intervention
โ†” On a small screen, swipe or scroll sideways to see the full table.

Critical Hemoglobin Results and Escalation

Hospital and laboratory policies define hemoglobin critical-value thresholds locally โ€” there is no one universal numeric cutoff for all institutions. Urgent nursing action depends on symptoms (syncope, chest pain, severe dyspnea), vital signs, bleeding, rate of Hgb decline, and institutional critical-result policy.

Critical Finding Threshold / Value Immediate Action
Symptomatic anemia with hemodynamic compromise Tachycardia, hypotension, chest pain, or syncope with low hemoglobin โ€” apply local critical policy and prescriber orders Escalate according to facility policy; notify prescriber urgently โ€” do not delay for pending peripheral smear or reticulocyte count alone when perfusion is compromised
Rapid Hgb decline with active bleeding Falling hemoglobin with melena, hematemesis, or post-procedure bleeding and rising transfusion need Notify prescriber; support type and screen or transfusion pathway per orders; reassess perfusion
Discordant stable Hgb with clinical worsening Reported Hgb unchanged while dizziness, dyspnea, or exercise tolerance worsen โ€” or after recent transfusion timing unclear Notify prescriber; repeat H&H per orders; evaluate outcomes with focused assessment and bleeding review
โ†” On a small screen, swipe or scroll sideways to see the full table.
Stop and Escalate

Stop routine workflow and escalate according to facility policy when perfusion is compromised, when symptomatic anemia is untreated, or when a mislabeled or wrong-tube specimen would drive unsafe transfusion or discharge decisions.

Factors Affecting Results

Hemoglobin interpretation requires trend awareness, volume status, transfusion timing, and parallel red cell indices. Nurses prevent false reassurance and false alarm by trending Hgb with symptoms and examination.

False Positives
  • Elevated Hgb from dehydration or hemoconcentration without true polycythemia
  • High Hgb soon after transfusion before equilibration โ€” still requires clinical correlation
  • Smoking or chronic hypoxia raising Hgb without polycythemia vera per NHLBI context
False Negatives
  • Hgb within reference while ongoing occult bleeding depletes stores โ€” repeat H&H may be needed
  • Dilutional anemia from IV fluids masking falling red cell mass
  • Single acceptable Hgb while symptoms and reticulocyte response suggest marrow or blood loss problem
Interfering Factors
  • Wrong tube, clotted sample, or hemolysis affecting analyzer read
  • Recent transfusion, IV fluids, or timing relative to bleeding episode
  • Age, sex, pregnancy, altitude, or medicines altering Hgb interpretation
Test Limitations

Hemoglobin cannot diagnose iron deficiency anemia, sickle cell disease, polycythemia vera, or bleeding source alone. It is not a substitute for HbA1c or reticulocyte response. Always use the reporting laboratory reference interval and integrate with CBC indices, iron studies, and examination per NHLBI anemia guidance.

Nursing Responsibilities

Nursing responsibilities center on safe EDTA collection, timely communication of trends with symptoms, transfusion coordination when ordered, and teaching that hemoglobin supplements โ€” not replaces โ€” clinical judgment.

Before the Test
โœ“Confirm hemoglobin, CBC, or serial H&H orders and transfusion prerequisites
โœ“Baseline fatigue, dizziness, orthostatic vitals, and bleeding history
โœ“Review oral iron, anticoagulants, and marrow-affecting medicines
โœ“Prepare lavender EDTA tube and label before draw
During the Test
โœ“Collect whole blood per venipuncture policy; mix gently per EDTA protocol
โœ“Monitor for vasovagal symptoms during venipuncture
โœ“Transport without avoidable delay per laboratory protocol
After the Test
โœ“Report results with focused assessment โ€” not the value alone
โœ“Trend Hgb with hematocrit, transfusion orders, and symptom recovery
โœ“Evaluate outcomes after iron or transfusion โ€” symptoms trump isolated marker changes
โœ“Reinforce when to report worsening dyspnea, syncope, or bleeding despite stable Hgb

Documentation

Documentation should link hemoglobin results to symptoms, bleeding history, and communication.

Example Nursing Note

“Hemoglobin collected 14:20 on lavender EDTA tube. Pre-draw: melena history, fatigue, dizziness on standing, HR 108/min. Hgb 6.8 g/dL (down from 9.2 g/dL yesterday) below reporting lab interval. Ferrous sulfate on MAR; type and crossmatch pending. Prescriber notified with symptom summary and read-back per policy โ€” transfusion evaluation ordered. Reassessment after first unit pending; evaluate outcomes with repeat H&H.”

Key Documentation Points
  • Collection time and tube type (lavender EDTA)
  • Bleeding history, fatigue, dizziness, and vital signs
  • Prior Hgb trend and parallel CBC or transfusion orders
  • Prescriber notification and read-back for critical or discordant results
  • Transfusion or iron therapy response with follow-up plan
  • Patient teaching on hemoglobin limits and symptom reporting

Patient and Family Education

Use plain language connecting symptoms with test purpose and follow-up.

โœ“Explain hemoglobin reflects oxygen-carrying capacity and is interpreted with blood count and other tests
โœ“Clarify hemoglobin is not the same as HbA1c (diabetes long-term sugar test)
โœ“Teach which symptoms to report (worsening shortness of breath, fainting, black stools, heavy bleeding)
โœ“Emphasize that improving hemoglobin may lag behind how you feel during iron or transfusion therapy
โœ“Describe that doctors may repeat H&H to monitor treatment response
โœ“Confirm follow-up plans and when to seek urgent review per facility guidance
๐Ÿ“š

Hemoglobin NCLEX practice questions

Practice NCLEX-style clinical judgment focused on Hemoglobin safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Genโ€“style items (including an ordered workflow step) and evaluate outcomes with the answer key.

Select a tab to view orders, results, assessment, and nursing note details for this case.

  • Order: Hemoglobin (CBC); repeat H&H; type and crossmatch โ€” medical unit anemia workup
  • Indication: 58-year-old on medical unit with fatigue, dizziness, and history of melena
  • Timing: Stat Hgb resulted this afternoon; prior Hgb 9.2 g/dL yesterday
  • Related orders: Hgb 6.8 g/dL; ferrous sulfate on MAR; type and crossmatch pending; repeat H&H ordered
Question 1 โ€” Priority action

After reviewing the case tabs, what is the nurse’s priority action?

Question 2 โ€” Recognize cues

Which findings from the case tabs require clarification or escalation before routine monitoring only? Select all that apply

Question 3 โ€” Trend interpretation

Which trends or events should the nurse recognize as concerning in this hemoglobin workup?

Trend snapshot
Hgb decreased from 9.2 g/dL to 6.8 g/dL over 24 hours; reports lightheadedness when standing

Select all that apply

Question 4 โ€” Matrix judgment

Classify each finding for this patient:

Finding Expected โ€” document and continue monitoring Requires follow-up โ€” notify team / repeat test Urgent โ€” immediate escalation
Hgb within reference with improving energy after transfusion and stable vitals
Hgb 6.8 g/dL with dizziness while type and crossmatch are pending
Hgb 6.8 g/dL with syncope and chest pain
Patient reassured that oral ferrous sulfate alone resolves critical anemia without prescriber review

On a small screen, swipe or scroll sideways to see the full table.

Question 5 โ€” Clinical judgment

Which statement best explains hemoglobin to a patient whose value is low and more tests are pending?

Question 6 โ€” Documentation (cloze)

Complete the priority documentation after stat hemoglobin collection in suspected GI bleeding:

The highest-priority documentation action is .

Question 7 โ€” Workflow (ordered response)

After critical low hemoglobin with dizziness and tachycardia is reported, rank nursing actions (1 = first).

  1. Document critical value, symptoms, read-back, and transfusion pathway in the chart
  2. Notify prescriber with critical hemoglobin; initiate critical-value protocol and focused cardiopulmonary assessment
  3. Assess dizziness, chest pain, bleeding, blood pressure, heart rate, and perfusion; apply fall precautions
  4. Reassess the patient, verify the order and identity, and prepare for prescriber follow-up
Question 8 โ€” Evaluate outcomes

Repeat hemoglobin six hours later shows 7.4 g/dL (up from 6.8) with improved dizziness but ongoing tachycardia 104/min and type and crossmatch pending. What outcome best shows safe follow-through?

Answer key & rationale

Frequently Asked Questions

FAQ

What does a hemoglobin blood test measure?

a hemoglobin test measures the amount of hemoglobin in blood โ€” the protein in red blood cells that carries oxygen throughout the body.

Is hemoglobin the same as HbA1c?

No. Hemoglobin (Hgb) measures oxygen-carrying protein in red blood cells for anemia and bleeding evaluation. HbA1c is a separate test reflecting average blood sugar over months โ€” do not use them interchangeably.

What does a low hemoglobin result mean?

Lower than normal hemoglobin may mean anemia per NHLBI guidance โ€” interpreted with symptoms, bleeding history, and other blood count results, not as a stand-alone diagnosis.

What does a high hemoglobin result mean?

Higher than normal hemoglobin may reflect dehydration, polycythemia, chronic hypoxia, or other causes listed by standard clinical references โ€” requiring clinical correlation and often additional evaluation.

Do reference ranges vary between laboratories?

Yes. reference ranges vary by laboratory, method, age, sex, and clinical context. Always use the interval printed on the patient’s result report.

When should nurses escalate despite stable or improving hemoglobin?

Escalate when dyspnea, syncope, chest pain, melena, heavy bleeding, or hypotension persist or worsen. Evaluate outcomes with perfusion and repeat H&H, not one Hgb value alone.

What related tests are often ordered with hemoglobin?

Hemoglobin is part of a complete blood count with hematocrit and red cell indices โ€” clinicians may add iron studies, reticulocyte count, or type and screen per orders.

References

References
  1. MedlinePlus. Hemoglobin Test. U.S. National Library of Medicine.
    https://medlineplus.gov/lab-tests/hemoglobin-test/
  2. National Heart, Lung, and Blood Institute. Anemia. U.S. Department of Health and Human Services.
    https://www.nhlbi.nih.gov/health/anemia
  3. DeLoughery TG. Anemia Screening. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
    https://www.ncbi.nlm.nih.gov/books/NBK499994/
  4. MedlinePlus. Blood Count Tests. U.S. National Library of Medicine.
    https://medlineplus.gov/lab-tests/blood-count-tests/
  5. National Institutes of Health, Genetic and Rare Diseases Information Center. Polycythemia vera.
    https://rarediseases.info.nih.gov/diseases/7437/polycythemia-vera
  6. Centers for Disease Control and Prevention. Anemia. National Center for Health Statistics.
    https://www.cdc.gov/nchs/fastats/anemia.htm
  7. National Heart, Lung, and Blood Institute. Iron-Deficiency Anemia. U.S. Department of Health and Human Services.
    https://www.nhlbi.nih.gov/health/anemia/iron-deficiency-anemia
  8. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia. WHO guideline document.
    https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3415

Editorial Standards & Medical Review

About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.

Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for Hemoglobin.

Policies: Medical Review Process ยท Editorial Policy ยท Correction Policy